Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
10.1186/s12885-015-1191-3
Saved in:
Main Authors: | Chong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
BioMed Central
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/127278 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
by: Muhammad Arifin Parenrengi, et al.
Published: (2022) -
Current evidence of temozolomide and bevacizumab in treatment of gliomas
by: Danop Nanegrungsunk, et al.
Published: (2018) -
Current evidence of temozolomide and bevacizumab in treatment of gliomas
by: Danop Nanegrungsunk, et al.
Published: (2018) -
Combined temozolomide and radiation as an initial treatment for anaplastic glioma
by: Tham, C.K., et al.
Published: (2016) -
Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis -retinoic acid in children with diffuse intrinsic pontine glioma
by: Nongnuch Sirachainan, et al.
Published: (2018)